Family Medicine · Glendale, CA
NPI
1073651550
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
800 S. Central Ave., Suite 308
Glendale, CA, 91204
Phone (818) 240-8767
Groups this clinician bills Medicare through
Medicare paid, 2024
$685K
10,206 services
Medicare patients, 2024
712
Average age 78
Drug cost, 2024
$2.4M
30,095 prescriptions
Company payments, 2025
$2,904
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saro Avakian was code 99232 (hospital e&m - subsequent), 1,622 times for 207 patients. In total Saro Avakian billed 10,206 services in 47 codes, and Medicare paid $685K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-09-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,622 | 207 | $65.56 | $106K |
| 99213 Office E&M - Established | Office | 1,089 | 380 | $78.17 | $85K |
| 99214 Office E&M - Established | Office | 739 | 378 | $103.10 | $76K |
| 99233 Hospital E&M - Subsequent | Facility | 737 | 197 | $98.52 | $73K |
| 82962 Clinical Chemistry | Office | 671 | 169 | $3.21 | $2,154 |
| 99442 Telephone Services | Office | 590 | 268 | $77.95 | $46K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 426 | 426 | $21.32 | $9,084 |
| 99497 Care Management/Coordination | Office | 423 | 422 | $86.51 | $37K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 413 | 413 | $21.31 | $8,800 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 385 | 385 | $141.70 | $55K |
| 99238 Hospital Discharge Management | Facility | 366 | 251 | $68.19 | $25K |
| 99212 Office E&M - Established | Office | 315 | 203 | $48.76 | $15K |
| 93000 Electrocardiogram | Office | 254 | 253 | $12.22 | $3,104 |
| 99222 Hospital E&M - Initial | Facility | 235 | 194 | $108.40 | $25K |
| 99443 Telephone Services | Office | 215 | 165 | $103.10 | $22K |
By year: 2022 $653K for 9,340 services; 2023 $688K for 9,782 services; 2024 $685K for 10,206 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 671 | 169 | $3.21 | $2,154 |
Medicare prescription drug claims, 2024
In 2024, the drug Saro Avakian prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,581 prescriptions and refills. In total Saro Avakian wrote 30,095 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,581 | 1,943 | 197 | $5,373 |
| Amlodipine Besylate Generic | 1,317 | 1,602 | 175 | $2,390 |
| Rosuvastatin Calcium Generic | 1,219 | 1,571 | 153 | $6,301 |
| Levothyroxine Sodium Generic | 934 | 1,117 | 104 | $4,484 |
| Metformin Hcl Generic | 921 | 1,104 | 113 | $2,010 |
| Losartan Potassium Generic | 867 | 1,082 | 109 | $3,639 |
| Pantoprazole Sodium Generic | 862 | 1,022 | 134 | $6,209 |
| Metoprolol Succinate Generic | 766 | 973 | 100 | $6,307 |
| Gabapentin Generic | 739 | 806 | 110 | $3,532 |
| Donepezil Hcl Generic | 671 | 762 | 75 | $2,178 |
| Omeprazole Generic | 601 | 698 | 81 | $1,794 |
| Ezetimibe Generic | 570 | 642 | 62 | $4,409 |
| Vascepa Icosapent Ethyl | 511 | 607 | 68 | $134K |
| Tamsulosin Hcl Generic | 504 | 648 | 78 | $3,396 |
| Furosemide Generic | 469 | 521 | 64 | $880 |
Brand drugs: 4,470 claims; generic drugs: 25,275 claims; opioid claims: 180.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saro Avakian $2,904 ($2,904 in general payments such as food, travel and fees) from 21 companies. The largest payer was Axsome Therapeutics, Inc. with $387.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 6 | $387 |
| Abbvie Inc. ABBV | 19 | $361 |
| Novo Nordisk Inc NVO | 7 | $348 |
| Ardelyx, Inc. ARDX | 8 | $257 |
| Lilly USA, LLC LLY | 8 | $238 |
| Amgen Inc. AMGN | 11 | $205 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $175 |
| Vertex Pharmaceuticals Incorporated VRTX | 3 | $162 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $93.34 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $85.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.